{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:30:30Z","timestamp":1787729430239,"version":"build-2784847793"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T00:00:00Z","timestamp":1425254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The purpose of this study was too describe the associated baseline features of AF patients with heart failure (HF) with reduced and preserved ejection fraction (HFrEF and HFpEF). Secondly, we assessed symptomatic status and their clinical correlates. Finally, we examined independent predictors for \u2018heart failure\u2019 at the 1-year follow-up period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A survey of European cardiologists from nine countries, participating in the EURObservational Research Programme Pilot survey on Atrial Fibrillation (EORP-AF Pilot), was carried out. Of the whole cohort of 2972 patients, 1411 (47.5%) had a diagnosis of HF. Of the AF patients with HF, oral anticoagulants were prescribed to 82.1% and antiarrhythmic drugs in 36.7%. Independent predictors of HFpEF were high body mass index, high heart rate, high systolic blood pressure, low diastolic blood pressure, high CHA2DS2-VASc score, and absence of chronic kidney disease, sleep apnoea, or ischaemic cardiomyopathy. On multivariate stepwise regression analysis, independent predictors of the development of HF were mode of AF presentation, diuretic use, prior HF, COPD, and valvular disease. At 1 year, HF was associated with a greater risk of all-cause mortality (log-rank test, P &amp;lt; 0.001). When HFrEF was compared with HFpEF at 1 year, crude rates were significant for the composite endpoint of \u2018stroke\/thrombo-embolism\/transient ischaemic attack and death\u2019 (15.9% vs. 11.1%, P = 0.043).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We provide insights into the clinical characteristics and outcomes in AF patients with HF, who were managed by European cardiologists. Despite a high prevalence of oral anticoagulant use, 1-year mortality and morbidity remained high in AF patients with HF, whether HFrEF or HFpEF. Such patients require a holistic approach to cardiovascular risk management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.254","type":"journal-article","created":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T06:38:49Z","timestamp":1425278329000},"page":"570-582","source":"Crossref","is-referenced-by-count":81,"title":["Heart Failure in Patients with Atrial Fibrillation in Europe: A Report from the Eurobservational Research Programme Pilot Survey on Atrial Fibrillation"],"prefix":"10.1093","volume":"17","author":[{"given":"Gregory Y.H.","family":"Lip","sequence":"first","affiliation":[{"name":"University of Birmingham Centre for Cardiovascular Sciences, City Hospital , Birmingham ,","place":["UK"]},{"name":"Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University , Aalborg ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Laroche","sequence":"additional","affiliation":[{"name":"EURObservational Research Programme Department, European Society of Cardiology, Sophia Antipolis \u00a0","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mircea I.","family":"Popescu","sequence":"additional","affiliation":[{"name":"Cardiology Department, Faculty of Medicine Oradea, Emergency Clinical County Hospital of Oradea \u00a0","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars H.","family":"Rasmussen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cardiovascular Research Centre, Aalborg University Hospital , Aalborg ,","place":["Denmark"]},{"name":"Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Medicine, Aalborg University , Aalborg ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Vitali-Serdoz","sequence":"additional","affiliation":[{"name":"University of Trieste, Ospedale di Cattinara, AOU Ospedali Riuniti SC Cardiologia , Trieste ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gheorghe-Andrei","family":"Dan","sequence":"additional","affiliation":[{"name":"Colentina University Hospital, Department of Cardiology , Bucharest ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Kalarus","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Silesian Center for Heart Disease , Zabrze ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J.G.M.","family":"Crijns","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Maastricht University Medical Centre , Maastricht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario M.","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Cardiology Department, Santa Marta Hospital and Institute of Physiology, Faculty of Medicine, University of Lisbon , Lisbon ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Tavazzi","sequence":"additional","affiliation":[{"name":"Maria Cecilia Hospital, GVM Care and Research, Ettore Sansavini Health Science Foundation , Cotignola ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo P.","family":"Maggioni","sequence":"additional","affiliation":[{"name":"EURObservational Research Programme Department, European Society of Cardiology, Sophia Antipolis \u00a0","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[{"name":"Institute of Cardiology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, S. Orsola-Malpighi University Hospital , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,3,2]]},"reference":[{"key":"2026011921091704400_ejhf254-bib-0001","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.amjcard.2014.01.002","article-title":"Atrial fibrillation and heart failure: a bad combination","volume":"113","author":"Lau","year":"2014","journal-title":"Am J Cardiol"},{"key":"2026011921091704400_ejhf254-bib-0002","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026011921091704400_ejhf254-bib-0003","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-000975","article-title":"Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study","volume":"2","author":"Lip","year":"2012","journal-title":"BMJ Open"},{"key":"2026011921091704400_ejhf254-bib-0004","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eut373","article-title":"A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry","volume":"16","author":"Lip","year":"2014","journal-title":"Europace"},{"key":"2026011921091704400_ejhf254-bib-0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1477-7525-5-37","article-title":"Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with atrial fibrillation (AF-QoL)","volume":"5","author":"Badia","year":"2007","journal-title":"Health Qual Life Outcomes"},{"key":"2026011921091704400_ejhf254-bib-0006","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/europace\/eup421","article-title":"Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation","volume":"12","author":"Arribas","year":"2010","journal-title":"Europace"},{"key":"2026011921091704400_ejhf254-bib-0007","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jchf.2013.11.002","article-title":"Outcomes of medicare beneficiaries with heart failure and atrial fibrillation","volume":"2","author":"Khazanie","year":"2014","journal-title":"JACC Heart Fail"},{"key":"2026011921091704400_ejhf254-bib-0008","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jacc.2009.01.055","article-title":"Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation","volume":"53","author":"Nieuwlaat","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026011921091704400_ejhf254-bib-0009","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nrcardio.2011.112","article-title":"The role of aspirin for stroke prevention in atrial fibrillation","volume":"8","author":"Lip","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"2026011921091704400_ejhf254-bib-0010","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.amjcard.2012.04.034","article-title":"Meta-analysis of cardiovascular outcomes with dronedarone in patients with atrial fibrillation or heart failure","volume":"110","author":"Chatterjee","year":"2012","journal-title":"Am J Cardiol"},{"key":"2026011921091704400_ejhf254-bib-0011","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2011.11.063","article-title":"Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study","volume":"59","author":"Swedberg","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026011921091704400_ejhf254-bib-0012","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11886-014-0545-9","article-title":"Current perspectives on systemic hypertension in heart failure with preserved ejection fraction","volume":"16","author":"Oktay","year":"2014","journal-title":"Curr Cardiol Rep"},{"key":"2026011921091704400_ejhf254-bib-0013","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s11897-014-0223-7","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"11","author":"Dhingra","year":"2014","journal-title":"Curr Heart Fail Rep"},{"key":"2026011921091704400_ejhf254-bib-0014","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.amjcard.2013.12.024","article-title":"Prognosis in patients hospitalized with permanent and nonpermanent atrial fibrillation in heart failure","volume":"113","author":"Taillandier","year":"2014","journal-title":"Am J Cardiol"},{"key":"2026011921091704400_ejhf254-bib-0015","doi-asserted-by":"crossref","first-page":"e000126","DOI":"10.1161\/JAHA.113.000126","article-title":"Atrial fibrillation patterns and risks of subsequent stroke, heart failure, or death in the community","volume":"2","author":"Lubitz","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2026011921091704400_ejhf254-bib-0016","doi-asserted-by":"crossref","first-page":"e005694","DOI":"10.1161\/JAHA.112.005694","article-title":"Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction","volume":"2","author":"McManus","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2026011921091704400_ejhf254-bib-0017","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation\u2014developed with the special contribution of the European Heart Rhythm Association","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"key":"2026011921091704400_ejhf254-bib-0018","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1160\/TH13-06-0443","article-title":"Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position Paper of the ESC Working Group on Thrombosis\u2014Task Force on Anticoagulants in Heart Disease","volume":"110","author":"De Caterina","year":"2013","journal-title":"Thromb Haemost"},{"key":"2026011921091704400_ejhf254-bib-0019","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1160\/TH13-07-0556","article-title":"Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation","volume":"110","author":"Gallego","year":"2013","journal-title":"Thromb Haemost"},{"key":"2026011921091704400_ejhf254-bib-0020","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.254","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/17\/6\/570\/66423340\/eurjhf_17_6_570.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/17\/6\/570\/66423340\/eurjhf_17_6_570.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:09:36Z","timestamp":1768874976000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/17\/6\/570\/8426578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,2]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,3,2]]},"published-print":{"date-parts":[[2015,6,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.254","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,6]]},"published":{"date-parts":[[2015,3,2]]}}}